Alabama Administrative Code
Title 420 - ALABAMA STATE BOARD OF HEALTH
Chapter 420-10-1 - CARE AND TREATMENT OF INFANTS IDENTIFIED THROUGH THE NEWBORN SCREENING PROGRAM
Section 420-10-1-.01 - Purpose

Universal Citation: AL Admin Code R 420-10-1-.01
Current through Register Vol. 42, No. 11, August 30, 2024

The purpose of these rules is to provide administrative details and procedures for the care and treatment of newborns identified with phenylketonuria, hypothyroidism, galactosemia, congenital adrenal hyperplasia, hearing loss, hemoglobinopathy, biotinidase deficiency, cystic fibrosis, aminoacidopathies, fatty acid oxidation disorders, organic acidurias and acidemias, critical congenital heart disease, severe combined immunodeficiency, spinal muscular atrophy, x-linked adrenoleukodystrophy, lysosomal storage disorders, and other heritable diseases.

Authors: P. Scott Harris, M.D., Thomas M. Miller, M.D., Lucinda G. Ashley, R.N. - B.C., Rachael N. Montgomery, B.S.N., R.N.

Statutory Authority: Code of Ala. 1975, §§ 22-2-2, 22-20-3.

Disclaimer: These regulations may not be the most recent version. Alabama may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.